UK Industry Warns Against Post-Brexit Regulatory Divergence
The MHRA Could Help Design ‘Gold Standard’ Practices
The UK must maintain a competitive regulatory framework at home, and its medicines agency should play a part in influencing international regulatory policy alongside other national and global organizations, says a new report from the ABPI.
